Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance
Zepbound® (tirzepatide) is an FDA-approved medication for weight loss. When paired with healthy habits, it's a valuable tool for qualifying adults looking to lose weight and improve their overall health.*
For just $99/month, our program includes all the support you need on your weight-loss journey, from provider visits and text-based Health Coaching** to educational resources and a community to root for you. Set yourself up for success and unveil the real you with Shed’s Zepbound® Membership. Medication not included.






Wegovy® is now available as a once-daily pill, offering a needle-free option for people who prefer oral medication. Like the Wegovy® pen, the pill contains semaglutide and is FDA-approved for chronic weight management.
This new delivery method gives patients more flexibility in how they take Wegovy®, while still receiving provider-guided care through Shed.

*In clinical trials of Wegovy® (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise. This compares to approximately 2–3% weight loss with diet and exercise alone.















*Zepbound® (tirzepatide) is FDA-approved for chronic weight management in adults with obesity or overweight who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. Individual results may vary. The most common side effects are gastrointestinal, including nausea, constipation, or mild bloating, which typically improve as your body adjusts. Zepbound® is a prescription medication and is prescribed only after consultation with a licensed healthcare provider to determine appropriateness.
**Text-based coaching is powered by AI and monitored by a licensed coach. Responses may be automated, but your coach reviews interactions to ensure quality and support.
†In clinical trials, participants taking Zepbound along with diet and exercise lost an average of up to 20% of their body weight. Individual results may vary
“Tirzepatide as Compared with Semaglutide for the Treatment of Obesity,” National Library of Medicine, May 11, 2025. https://pubmed.ncbi.nlm.nih.gov/40353578/




Zepbound® (tirzepatide) is an FDA-approved medication for weight loss. When paired with healthy habits, it's a valuable tool for qualifying adults looking to lose weight and improve their overall health.*
For just $99/month, our program includes all the support you need on your weight-loss journey, from provider visits and text-based Health Coaching** to educational resources and a community to root for you. Set yourself up for success and unveil the real you with Shed’s Zepbound® Membership. Medication not included.




Zepbound® (tirzepatide) is an FDA-approved medication for weight loss. When paired with healthy habits, it's a valuable tool for qualifying adults looking to lose weight and improve their overall health.*
For just $99/month, our program includes all the support you need on your weight-loss journey, from provider visits and text-based Health Coaching** to educational resources and a community to root for you. Set yourself up for success and unveil the real you with Shed’s Zepbound® Membership. Medication not included.




Doctor of Medicine (MD),
Internal Medicine Physician
While GLP-1 microdosing is ideal for maintenance, longevity, and overall wellness support, those with a significant weight-loss goal may be better suited for a standard GLP-1 dose.

*Zepbound® (tirzepatide) is FDA-approved for chronic weight management in adults with obesity or overweight who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. Individual results may vary. The most common side effects are gastrointestinal, including nausea, constipation, or mild bloating, which typically improve as your body adjusts. Zepbound® is a prescription medication and is prescribed only after consultation with a licensed healthcare provider to determine appropriateness.
**Text-based coaching is powered by AI and monitored by a licensed coach. Responses may be automated, but your coach reviews interactions to ensure quality and support.
†In clinical trials, participants taking Zepbound along with diet and exercise lost an average of up to 20% of their body weight. Individual results may vary
“Tirzepatide as Compared with Semaglutide for the Treatment of Obesity,” National Library of Medicine, May 11, 2025. https://pubmed.ncbi.nlm.nih.gov/40353578/
Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance